Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Circulation|April 18, 2001
Fluvastatin lowers atherogenic dense low-density lipoproteins in postmenopausal women with the atherogenic lipoprotein phenotypeW März, H Scharnagl, C Abletshauser, et al.Biosensors & Bioelectronics|September 24, 2008
Nanotechnologic biosensor ellipsometry and biomarker pattern analysis in the evaluation of atherosclerotic risk profileG Siegel, M Rodríguez, F Sauer, et al.European Journal of Clinical Investigation|April 29, 2009
Fluvastatin/fenofibrate vs. simvastatin/ezetimibe in patients with metabolic syndrome: different effects on LDL-profilesK Winkler, T Schewe, G Pütz, et al.European Journal of Clinical Pharmacology|April 25, 2001
Effects of fluvastatin on biliary lipids in subjects with an elevated cholesterol saturation indexM Porsch-Ozçürümez, P D Hardt, H Schnell-Kretschmer, et al.Journal of Thrombosis and Haemostasis : JTH|March 12, 2010
A randomized, double-blind study of certoparin vs. unfractionated heparin to prevent venous thromboembolic events in acutely ill, non-surgical patients: CERTIFY StudyH Riess, S Haas, U Tebbe, et al.Journal of Biological Regulators and Homeostatic Agents|April 11, 2006
Monitoring of peripheral blood cytotoxic T-cells under fluvastatin treatment in renal transplant recipientsS Barlage, I A Hauser, R Elbracht, et al.Atherosclerosis|March 20, 2001
Fluvastatin therapy improves microcirculation in patients with hyperlipidaemiaE Haak, C Abletshauser, S Weber, et al.Thrombosis Research|June 11, 2011
Certoparin versus UFH to prevent venous thromboembolic events in the very elderly patient: an analysis of the CERTIFY studyS M Schellong, H-E Gerlach, U Tebbe, et al.Thrombosis and Haemostasis|April 21, 2011
CERTIFY: prophylaxis of venous thromboembolism in patients with severe renal insufficiencyR Bauersachs, S M Schellong, S Haas, et al.Pageof 2